Sangamo BioSciences, Inc. Announces Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference

RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo’s president and CEO, will provide an update on the progress of Sangamo’s ZFP Therapeutic®development programs and an overview of the company’s business strategy at 9:10 am ET on Tuesday, August 14, 2012, at the 2012 Wedbush PacGrow Lifesciences Management Access Conference which will be held in New York City.